Inhibitory effects of NGX6 gene on EGFR/K-ras/JNK/c-Jun/cyclin D1 signal pathway in the colon cancer

Progress in Biochemistry and Biophysics

Volumn 35, Issue 5, 2008, Pages 570-576

  Wang, Xiao Yan ^a,b   Shen, Shou Rong ^a   Liu, Fen ^a   Peng, Ya ^a   Li, Gui Yuan ^b   Fan, Song Qing ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Colon cancer; EGFR; JNK pathway; NGX6 gene

Indexed keywords

MUS MUSCULUS;

EID: 48249156231     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Xie Y, Bin L H, Yang J B. Chin Med J, 2001, 114(5): 530-534
2. Zhang X M, Shen S R, Wang X Y, et al. World Chinese Journal of Digestology, 2002, 10(8): 873-876
3. Wang X Y, Shen S R, Liu H Y, et al. World Chinese Journal of Digestology, 2004, 12(3): 574-579
4. Wang X Y, Shen S R, Liu F, et al. Progress in Biochemistry and Biophysics, 2006, 33(1): 45-50
5. Fromowitz F B, Voila M V, Chao S, et al. Ras P21 expression in the progression of breast cancer. Humanpathol, 1987, 18(12): 1268-1275
6. Schmelz E M, Xu H, Sengupta R, et al. Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein. Cancer Res, 2007, 67(11): 5389-5396
7. Banu N, Buda A, Chell S, et al. Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy. Cell Prolif, 2007, 40(5): 768-779
8. Bralet M P, Paule B, Falissard B, et al. Immunohistochemical variability of epidermal growth factor receptor (EGFR) in liver metastases from colonie carcinomas. Histopathology, 2007, 50(2): 210-216
9. Azuma M, Danenberg K D, Iqbal S, et al. Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer. Clin Colorectal Cancer, 2006, 6(3): 214-218
10. Ogunwobi O O, Beales I L. The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis, 2007, 22(4): 401-409
11. Gresch S, Tegeder I, Schilling K, et al. Activation of c-Jun-N-terminal-kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers. FASEB J, 2003, 7(10): 1316-1318
12. Cui J, Zhang M, Zhang Y Q, et al. JNK pathway: diseases and therapeutic potential. Acta Pharmacol Sin, 2007, 28(5): 601-608
13. Minden A, Lin A, Smeal T, et al. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinase. Mol Cell Biol, 1994, 14: 6683
14. Bakiri L, Lallemand D, Ella B W, et al. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin Dl expression. EMBO J, 2000, 19(9): 2056-2068
15. Sherr CJ. D-type cyclins. Trends Biochem Sci, 1995, 20(5): 187-190